Literature DB >> 16227296

Activation of Kaposi's sarcoma-associated herpesvirus lytic gene expression during epithelial differentiation.

Andrew S Johnson1, Nicole Maronian, Jeffrey Vieira.   

Abstract

The oral cavity has been identified as the major site for the shedding of infectious Kaposi's sarcoma-associated herpesvirus (KSHV). While KSHV DNA is frequently detected in the saliva of KSHV seropositive persons, it does not appear to replicate in salivary glands. Some viruses employ the process of epithelial differentiation for productive viral replication. To test if KSHV utilizes the differentiation of oral epithelium as a mechanism for the activation of lytic replication and virus production, we developed an organotypic raft culture model of epithelium using keratinocytes from human tonsils. This system produced a nonkeratinized stratified squamous oral epithelium in vitro, as demonstrated by the presence of nucleated cells at the apical surface; the expression of involucrin and keratins 6, 13, 14, and 19; and the absence of keratin 1. The activation of KSHV lytic-gene expression was examined in this system using rKSHV.219, a recombinant virus that expresses the green fluorescent protein during latency from the cellular EF-1alpha promoter and the red fluorescent protein (RFP) during lytic replication from the viral early PAN promoter. Infection of keratinocytes with rKSHV.219 resulted in latent infection; however, when these keratinocytes differentiated into a multilayered epithelium, lytic cycle activation of rKSHV.219 occurred, as evidenced by RFP expression, the expression of the late virion protein open reading frame K8.1, and the production of infectious rKSHV.219 at the epithelial surface. These findings demonstrate that KSHV lytic activation occurs as keratinocytes differentiate into a mature epithelium, and it may be responsible for the presence of infectious KSHV in saliva.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227296      PMCID: PMC1262565          DOI: 10.1128/JVI.79.21.13769-13777.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  97 in total

1.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.

Authors:  C Meyers; M G Frattini; J B Hudson; L A Laimins
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.

Authors:  M Hummel; J B Hudson; L A Laimins
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Epstein-Barr virus infection and replication in a human epithelial cell system.

Authors:  Q X Li; L S Young; G Niedobitek; C W Dawson; M Birkenbach; F Wang; A B Rickinson
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

4.  Keratins as molecular markers of epithelial differentiation: differential expression in crypt epithelium of human palatine tonsils.

Authors:  D Mischke; T Genka; G Wille; H Lobeck; A G Wild
Journal:  Ann Otol Rhinol Laryngol       Date:  1991-05       Impact factor: 1.547

5.  Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia.

Authors:  J A Thomas; D H Felix; D Wray; J C Southam; H A Cubie; D H Crawford
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

6.  Three distinct keratinocyte subtypes identified in human oral epithelium by their patterns of keratin expression in culture and in xenografts.

Authors:  K Lindberg; J G Rheinwald
Journal:  Differentiation       Date:  1990-12       Impact factor: 3.880

7.  Epithelial-specific gene expression during differentiation of stratified primary human keratinocyte cultures.

Authors:  J L Wilson; S C Dollard; L T Chow; T R Broker
Journal:  Cell Growth Differ       Date:  1992-08

8.  Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma.

Authors:  F Smedts; F Ramaekers; R E Leube; K Keijser; M Link; P Vooijs
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

9.  Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia.

Authors:  L S Young; R Lau; M Rowe; G Niedobitek; G Packham; F Shanahan; D T Rowe; D Greenspan; J S Greenspan; A B Rickinson; P J Farrell
Journal:  J Virol       Date:  1991-06       Impact factor: 6.549

10.  Mutual induction of growth factor gene expression by epidermal-dermal cell interaction.

Authors:  H Smola; G Thiekötter; N E Fusenig
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

View more
  25 in total

1.  Efficient replication of Epstein-Barr virus in stratified epithelium in vitro.

Authors:  Rachel M Temple; Junjia Zhu; Lynn Budgeon; Neil David Christensen; Craig Meyers; Clare E Sample
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

2.  Human Cytomegalovirus Productively Replicates In Vitro in Undifferentiated Oral Epithelial Cells.

Authors:  Chao Weng; Denis Lee; Christopher B Gelbmann; Nicholas Van Sciver; Dhananjay M Nawandar; Shannon C Kenney; Robert F Kalejta
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

3.  Macaque homologs of Kaposi's sarcoma-associated herpesvirus (KSHV) infect germinal center lymphoid cells, epithelial cells in skin and gastrointestinal tract and gonadal germ cells in naturally infected macaques.

Authors:  Helle Bielefeldt-Ohmann; A Gregory Bruce; Kellie Howard; Minako Ikoma; Margaret E Thouless; Timothy M Rose
Journal:  Virology       Date:  2018-04-22       Impact factor: 3.616

4.  Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus.

Authors:  Melanie M Brinkmann; Marcel Pietrek; Oliver Dittrich-Breiholz; Michael Kracht; Thomas F Schulz
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

5.  Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.

Authors:  Danyang Gong; Xinghong Dai; Yuchen Xiao; Yushen Du; Travis J Chapa; Jeffrey R Johnson; Xinmin Li; Nevan J Krogan; Hongyu Deng; Ting-Ting Wu; Ren Sun
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

6.  Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhiheng He; Yunhua Liu; Deguang Liang; Zhuo Wang; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

7.  X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.

Authors:  Sam J Wilson; Edward H Tsao; Benjamin L J Webb; Hongtao Ye; Lucy Dalton-Griffin; Christoforos Tsantoulas; Catherine V Gale; Ming-Qing Du; Adrian Whitehouse; Paul Kellam
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication.

Authors:  Danyang Gong; Nicholas C Wu; Yafang Xie; Jun Feng; Leming Tong; Kevin F Brulois; Harding Luan; Yushen Du; Jae U Jung; Cun-yu Wang; Mo Kwan Kang; No-Hee Park; Ren Sun; Ting-Ting Wu
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

9.  KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.

Authors:  William Wu; Jeffrey Vieira; Nancy Fiore; Prabal Banerjee; Michelle Sieburg; Rosemary Rochford; William Harrington; Gerold Feuer
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

10.  The ORF59 DNA polymerase processivity factor homologs of Old World primate RV2 rhadinoviruses are highly conserved nuclear antigens expressed in differentiated epithelium in infected macaques.

Authors:  A Gregory Bruce; Angela M Bakke; Courtney A Gravett; Laura K DeMaster; Helle Bielefeldt-Ohmann; Kellie L Burnside; Timothy M Rose
Journal:  Virol J       Date:  2009-11-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.